Navigation Links
Arthritis Foundation bestows prestigious national research award

ATLANTA, Dec. 1, 2008 The Arthritis Foundation announces the 2008 winners of the Lee C. Howley Sr. Prize for research in arthritis. The recipients, Dr. Gerard Karsenty of the Columbia University College of Physicians and Dr. Michel Nussenzweig of Rockefeller University received the award for their continued research advancements in the cure and control of rheumatic diseases.

Dr. Karsenty is recognized for his research in the development and function of the skeletal system. A graduate of the University of Paris, Dr. Karsenty received his postdoctoral fellow in the laboratory of Dr. Benoit de Crombrugghe. Prior to Dr. Karsenty's work, little was known about the molecular basis of mammalian skeletal system development and differentiation. Now, a decade later, the field is burgeoning with a plethora of new transcription factors, coactivators, corepressors, and signaling pathways that explain the development of the osteoblast from the mesenchymal stem cell, both during embryonic development and during postnatal bone formation. Dr. Karsenty is currently the Paul. A. Marks M.D. Professor and Chairman of the Department of Genetics and Development at Columbia University College of Physicians and Surgeons in New York City.

Dr. Nussenzweig is recognized for his contributions to the fields of B cell development and dendritic cell function. These studies have been crucial in providing insights into the etiology of autoimmune diseases such as rheumatoid arthritis and have paved the way to the development of novel therapies for the treatment of these diseases. After completing a medical internship, residency, and infectious disease fellowship at the Massachusetts General Hospital, Dr. Nussenzweig joined Dr. Philip Leder in the department of genetics at Harvard Medical School for postdoctoral training. Dr. Nussenzweig currently heads the laboratory of Molecular Immunology at Rockefeller University.


Contact: Carol Galbreath
Arthritis Foundation

Page: 1

Related medicine news :

1. Arthritis Foundation Renews Comprehensive Marketing Contract with Merkle
2. New Therapy Could Transform Arthritis Treatment
3. The SCOOTER Store Donates Power Wheelchair to Former Manassas Detective Stricken With Arthritis
4. Medicaid policies vary widely for rheumatoid arthritis drugs
5. Wide variability in rheumatoid arthritis drug suggests alternative dosing should be considered
6. Arthritis Foundation Honors Comerica Bank at Commitment To A Cure Awards Gala
7. Biologics Dont Raise Cancer Risk in Rheumatoid Arthritis Patients
8. Rheumatoid Arthritis May Harm Gums
9. New Study Highlights Need for Better Interaction and Education Between Rheumatoid Arthritis Patients and Care Providers
10. Rheumatoid Arthritis a Threat to the Heart
11. Rheumatoid Arthritis Rising Among U.S. Women
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
Breaking Medicine Technology: